• Precision Use of Pazopanib (GW-786034) in Advanced Cancer Mo

  2026-04-27

  Explore how Pazopanib (GW-786034) redefines precision cancer research through advanced mechanistic insights, context-driven protocol optimization, and data-backed application in ATRX-deficient tumor models. This article uniquely bridges molecular pharmacology with practical assay decisions.

• Sunitinib: Multi-Targeted RTK Inhibitor in Renal Cell Carcin

  2026-04-27

  Sunitinib empowers cancer researchers with precise, multi-pathway RTK inhibition and robust anti-angiogenic effects, now further enhanced by innovative combination strategies. Explore actionable workflows, protocol optimizations, and cutting-edge applications in renal cell carcinoma and beyond.

• Salinomycin as a Polyether Ionophore: Mechanistic Insights f

  2026-04-26

  Explore the mechanistic depth of Salinomycin, a polyether ionophore antibiotic, in hepatocellular carcinoma research. This article uniquely integrates molecular transport mechanisms, cytotoxicity considerations, and advanced protocol guidance for maximizing experimental rigor.

• Resiniferatoxin (RTX): Transforming Analgesia Research in OA

  2026-04-25

  Resiniferatoxin (RTX) stands out as a selective and ultra-potent TRPV1 agonist, delivering unprecedented nerve desensitization and durable pain relief in preclinical and clinical models of osteoarthritis. With precise dosing and robust safety profiles, RTX unlocks advanced workflows for dissecting pain pathways and developing next-generation analgesic agents.

• BH3 Mimetics Target Senescent Cells in TP53 Wild-Type Breast

  2026-04-24

  This study demonstrates that BH3 mimetics, specifically BCL-XL inhibitors, selectively eliminate chemotherapy-induced senescent breast cancer cells in TP53 wild-type settings. The findings highlight a strategy to minimize residual disease and improve outcomes in patient populations that typically show poor chemotherapy responses.

• GPR107 Deficiency Drives Diabetic Nephropathy via AT1R/Ca2+

  2026-04-24

  Xu et al. (2025) reveal that loss of GPR107 in podocytes intensifies diabetic nephropathy by disrupting clathrin-mediated endocytosis of AT1R, thus aberrantly activating calcium signaling and promoting collagen IV accumulation. These results clarify a mechanistic link between impaired endocytosis, Ca2+ signaling, and glomerular damage, suggesting GPR107 as a potential therapeutic target for kidney complications in diabetes.

• SU 5402: Applied Workflows for Cancer Biology & Neuronal Mod

  2026-04-23

  SU 5402 stands out as a versatile inhibitor for dissecting receptor tyrosine kinase signaling in both cancer and neuronal research. This article details experimental workflows, protocol optimizations, and troubleshooting tips that maximize the compound’s value, with insights drawn from validated human iPSC-neuron and oncology models.

• WZ4003: Applied Uses of a Potent NUAK1/2 Inhibitor in Cell a

  2026-04-23

  WZ4003 unlocks precision control over NUAK1/2 signaling, enabling researchers to dissect cell migration, proliferation, and tau phosphorylation with high specificity. This guide covers detailed workflows, assay enhancements, and troubleshooting strategies that maximize reproducibility and insight using APExBIO’s WZ4003.

• Methyl-β-cyclodextrin: Practical Guide for Cholesterol Extra

  2026-04-22

  Methyl-β-cyclodextrin is a high-purity reagent for selective cholesterol and lipid extraction from cell membranes, supporting studies in membrane fluidity and lipid raft dynamics. It is intended for controlled research use and not for diagnostic or medical applications, with strict recommendations on solution freshness and storage. Researchers should follow specified protocol and QC parameters to maximize reproducibility and avoid common pitfalls.

• Advancing In Vitro Drug Response Metrics in Cancer Research

  2026-04-22

  Schwartz's dissertation introduces an innovative framework for distinguishing between proliferative arrest and cell death in cancer drug studies, revealing that most agents—including topoisomerase 1 inhibitors—impact both parameters with distinct kinetics. These insights refine assay interpretation and support more accurate evaluation of antitumor agents in preclinical research.

• DiD (DiDC 18 (5)) for High-Fidelity Plasma Membrane Staining

  2026-04-21

  DiD (DiDC 18 (5)) delivers uniform, robust plasma membrane labeling, ideal for tracking cell migration and neuronal pathways—even in autofluorescent or inflammatory microenvironments. This guide translates recent innovations and practical workflows into actionable protocols, troubleshooting, and advanced use-cases for next-generation cell biology.

• AICAR Phosphate (Acadesine): Optimized Workflows for B-CLL A

  2026-04-21

  AICAR phosphate (Acadesine) from APExBIO enables precise, AMPK-driven apoptosis induction in B-cell chronic lymphocytic leukemia (B-CLL) research, with robust selectivity and mitochondrial pathway engagement. This guide delivers evidence-based protocols, advanced troubleshooting, and practical insights inspired by the latest mechanistic studies.

• Scenario-Driven Best Practices: Dibutyryl-cAMP, Sodium Salt

  2026-04-20

  This article addresses common laboratory challenges in cAMP signaling pathway research, cell viability, and proliferation assays, demonstrating how Dibutyryl-cAMP, sodium salt (SKU B9001) from APExBIO provides reliable, reproducible, and cost-efficient solutions. Drawing on real-world scenarios and literature-backed practices, it guides scientists in optimizing assay design and interpretation using this stable cAMP analog.

• Amiloride (MK-870): ENaC Inhibition and Research Boundaries

  2026-04-20

  Amiloride (MK-870) is a validated epithelial sodium channel (ENaC) inhibitor supplied by APExBIO. It is widely used in sodium channel research and studies on cellular endocytosis modulation. Benchmarks highlight its specificity, storage parameters, and mechanistic limits for ion transport and receptor pathway investigations.

• Notopterol Modulates Macrophage Metabolism via α7nAChR in Sy

  2026-04-19

  This study reveals that Notopterol, a natural compound, attenuates synovitis by reprogramming macrophage metabolism through the α7 nicotinic acetylcholine receptor (α7nAChR). The findings highlight a novel mechanism where metabolic shifts from glycolysis to oxidative phosphorylation promote anti-inflammatory macrophage polarization, offering a promising therapeutic avenue for inflammatory arthritis.

15465 records 1/1031 page Next 12345 下5页 Last page